CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. (Q53242824)

12 May 2018

title

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. (English)

1 reference

12 May 2018

author

Morten Nielsen

7

1 reference

12 May 2018

Anders Elm Pedersen

12

1 reference

12 May 2018

Soren Buus

13

1 reference

12 May 2018

Anette Stryhn

Anette Stryhn

5

0 references

Ole Lund

Ole Lund

15

0 references

Claus Lundegaard

8

Claus Lundegaard

1 reference

12 May 2018

Kasper Lamberth

2

Kasper Lamberth

1 reference

12 May 2018

Mingjun Wang

1

Mingjun Wang

1 reference

12 May 2018

Sheila T Tang

9

Sheila T Tang

1 reference

12 May 2018

Mogens H Claesson

14

Mogens H Claesson

1 reference

12 May 2018

author name string

Mikkel Harndahl

3

1 reference

12 May 2018

Gustav Røder

4

1 reference

12 May 2018

Mette V Larsen

6

1 reference

12 May 2018

Morten H Dziegiel

10

1 reference

12 May 2018

Jørgen Rosenkvist

11

1 reference

12 May 2018

language of work or name

English

0 references

publication date

29 December 2006

1 reference

12 May 2018

published in

Vaccine

1 reference

12 May 2018

volume

25

1 reference

12 May 2018

issue

15

1 reference

12 May 2018

page(s)

2823-2831

1 reference

12 May 2018

Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Avian influenza A (H5N1) infection in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Influenza: lessons from past pandemics, warnings from current incidents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Cytotoxic T-cell immunity to influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Heterologous protection against influenza by injection of DNA encoding a viral protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Definition of supertypes for HLA molecules using clustering of specificity matrices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Design and use of conditional MHC class I ligands.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Reliable prediction of T-cell epitopes using neural networks with novel sequence representations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

SARS CTL vaccine candidates; HLA supertype-, genome-wide scanning and biochemical validation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Efficient assembly of recombinant major histocompatibility complex class I molecules with preformed disulfide bonds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Vaccination with p53-peptide-pulsed dendritic cells, of patients with advanced breast cancer: report from a phase I study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

Characterization of a new H-2D(k)-restricted epitope prominent in primary influenza A virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.12.038

10.1016/J.VACCINE.2006.12.038

7 January 2021

Identifiers

DOI

1 reference

12 May 2018

release_slucr3wsfretldytbls22qs67u

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/slucr3wsfretldytbls22qs67u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

17254671

1 reference

12 May 2018